about
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.Hairy cell leukemia: short review, today's recommendations and outlook.Potential breakthroughs with investigational drugs for hairy cell leukemia.Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors.Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemo-immunotherapy for hairy cell leukemia.
@en
Chemo-immunotherapy for hairy cell leukemia.
@nl
type
label
Chemo-immunotherapy for hairy cell leukemia.
@en
Chemo-immunotherapy for hairy cell leukemia.
@nl
prefLabel
Chemo-immunotherapy for hairy cell leukemia.
@en
Chemo-immunotherapy for hairy cell leukemia.
@nl
P2860
P1433
P1476
Chemo-immunotherapy for hairy cell leukemia.
@en
P2860
P356
10.3109/10428194.2011.565096
P478
52 Suppl 2
P577
2011-03-21T00:00:00Z